IQVIA Holdings (IQV) Expands Its Veeva Tie Up, Is It Still 6% Undervalued?

IQVIA Holdings (IQV) is back in focus after selecting Veeva CTMS, eTMF, Study Startup, and Site Connect as standard tools across its clinical development work, extending an earlier collaboration on electronic data capture.

That technology update lands at a time when IQVIA Holdings has already been regaining momentum, with a 1 day share price return of 3.28% and a 90 day share price return of 33.43% feeding into a 1 year total shareholder return of 26.98%. This suggests sentiment has been improving ahead of the upcoming earnings report.

Scan how IQVIA Holdings fits alongside other clinically focused data and healthcare technology players by reviewing our hand picked 37 healthcare AI stocks.

After a 33% move in 90 days, the real tension around IQVIA Holdings now sits in the gap between its recent price and the range of fair value estimates. How wide is that gap really?

Most Popular Narrative: 6% Undervalued

On the most followed view of IQVIA Holdings, a fair value of about $295 sits modestly above the recent $276.63 close. This puts the focus squarely on whether the existing growth engine can justify that gap.

The main thing that has to go right is that IQVIA Holdings continues to convert strong R&DS bookings, a large backlog and growing Commercial Solutions activity, including with emerging biopharma customers, into sustained revenue and earnings growth despite margin and debt headwinds.

See why 19 investors see IQVIA Holdings as 6% undervalued.

Result: Fair Value of $295.05 (UNDERVALUED)

Still, heavy leverage of around 3.6x adjusted EBITDA and ongoing pricing pressure across CRO contracts could quickly challenge the 6% undervalued narrative for IQVIA Holdings.

Find out about the key risks to this IQVIA Holdings narrative.

Next Steps

Mixed on IQVIA Holdings after all of this. If you want to move quickly and rely on your own judgment, start by weighing its 3 key rewards and 2 important warning signs.

Looking for more investment ideas beyond IQVIA Holdings?

If IQVIA Holdings has your attention, do not stop here. Cast a wider net and use data driven tools to pressure test your next move.

• Target potential mispricings by scanning a curated 33 high quality undervalued stocks that filters for quality fundamentals at what may be attractive entry points.
• Prioritise staying power by reviewing a list of solid balance sheet and fundamentals (25 results) that focuses on companies with stronger financial footing and cleaner balance sheets.
• Get ahead of the crowd by checking a 21 high quality undiscovered gems that highlights lesser known businesses with strong underlying metrics before they hit every watchlist.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com